Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1991-02-26
1994-02-15
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Lymphokine
435947, 530350, 530822, A61K 39002
Patent
active
052864839
ABSTRACT:
The invention concerns antigens from the intraerythrocytic phase of Plasmodium falciparum, namely: a protein of 50 kDa with an isoelectric point of 5.5 and a protein of 65 kDa separated by electrophoresis in reducing conditions into two polypeptides of 47 and 18 kDa, both appearing in the serum of patients infected by Plasmodium falciparum or in the culture medium of this microorganism during its intraerythrocytic phase, as well as a protein of 126 kDa synthesized during the nuclear multiplication phase during schizogony and localized on the periphery of the schizonts at the parasitophore vacuole level, precursor of the 50 kDa and 65 kDa proteins. Application of these proteins in the preparation of vaccines against malaria, and monoclonal antibodies corresponding to the assay of the antibodies of an immunized subject and assay of the antigens according to the invention during an attack of malaria.
REFERENCES:
patent: 4767622 (1988-08-01), Ristic et al.
patent: 4835259 (1989-05-01), Reese et al.
patent: 5116755 (1992-05-01), Kemp et al.
A. Bhatra et al. Am. J. Trop. Med. Hyg. 36:15-19 1987.
Lyon & Haynes P.falerparum Ag Synthesized by Schezonts . . . J. Immunology 136(6):2245-2251 Mar. 15, 1986.
Weber et al., Molecular Strategies of Parasitic Invasion, 1987 Alan R. Liss Inc., pp. 379-388.
Ravetch et al, Bio/Technology vol. 3, 1985, pp. 729-740
Ramasamy et al, J. Immunol. 134(3) 1985, pp. 1952-1955.
Holder et al, Nature 317, 1985, pp. 270-273.
Holder et al Nature, 294, 1981 pp. 361-364.
Mc Garvey et al PNAS 81, 1984, pp. 3690-3694.
Wiser, Eur J. Cell Biol 42, 1986, pp. 45-51.
Hall et al Nature 311, 1984, pp. 379-382.
Lyon et al PNAS 83, 1986, pp. 2989-2993.
De Silva; Bull WHO 61, 1983, pp. 105-112.
Lyon et al, J Immunol 136(1) 1986, pp. 2253-2258.
Odink et al FEBS 1984 vol. 173(1) pp. 108-112.
Delplan et al CA vol. 103, 1985, #212 923y.
Person et al, J Immunol 134(3) 1985, pp. 1946-1951.
Myler et al., CA vol. 99, 1983, #15009C.
Deplace Patrick
Dubrometz Francois J.
Fortier Bernard
Vernes Alain
Draper Garnette D.
Spector Lorraine M.
LandOfFree
50 kilodalton antigen obtained from the intraerythrocytic phase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 50 kilodalton antigen obtained from the intraerythrocytic phase , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 50 kilodalton antigen obtained from the intraerythrocytic phase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1205020